Literature DB >> 21089169

Alterations in biomarkers of endothelial function following on-pump coronary artery revascularization.

Ioannis Panagiotopoulos1, George Palatianos, Argyris Michalopoulos, Antonios Chatzigeorgiou, Sotirios Prapas, Elli F Kamper.   

Abstract

BACKGROUND: Cardiopulmonary bypass (CPB) has been associated with activation and injury of endothelial cells, probably responsible for the systemic inflammatory response syndrome (SIRS) taking place in these patients.
METHODS: We measured plasma concentrations of soluble P-selectin (sP-s), E-selectin (sE-s), tetranectin (TN), vonWillebrand factor (vWF) levels, and angiotensin-converting enzyme (ACE) activity in 31 adult patients undergoing elective coronary artery bypass grafting, just before and up to three days after surgery, and in 25 healthy volunteers.
RESULTS: Patients showed higher plasma sP-s and sE-s and ACE concentrations, just before surgery, but significantly lower TN levels, compared with controls. During the first three postoperative days (PD), the concentration of each of the molecules followed a different and independent pattern, although in the third PD, the levels of sP-s, sE-s and ACE were higher and those of vWF and TN lower, compared with the preoperative ones. However, patients had higher sP-s (P=0.06), sE-s (P=0.07), and vWF (P=0.005), but lower TN concentrations (P=0.02) on the third PD compared with controls.
CONCLUSIONS: CPB is characterised by pronounced changes in plasma sP-s, sE-s, TN, vWF levels, and ACE activity, which are associated with significant alteration in the intra- and early postoperative endothelial function observed in open heart surgery.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21089169      PMCID: PMC6647629          DOI: 10.1002/jcla.20416

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

Review 1.  von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?

Authors:  G Y Lip; A Blann
Journal:  Cardiovasc Res       Date:  1997-05       Impact factor: 10.787

2.  Expression of soluble endothelial adhesion molecules in clinical cardiopulmonary bypass.

Authors:  J Galea; N Rebuck; A Finn; A Manché; N Moat
Journal:  Perfusion       Date:  1998-09       Impact factor: 1.972

Review 3.  Characterizing the inflammatory response to cardiopulmonary bypass in children.

Authors:  Deborah J Kozik; James S Tweddell
Journal:  Ann Thorac Surg       Date:  2006-06       Impact factor: 4.330

4.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.

Authors:  S J Hwang; C M Ballantyne; A R Sharrett; L C Smith; C E Davis; A M Gotto; E Boerwinkle
Journal:  Circulation       Date:  1997-12-16       Impact factor: 29.690

5.  Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis.

Authors:  F Ribichini; G Steffenino; A Dellavalle; G Matullo; E Colajanni; T Camilla; A Vado; G Benetton; E Uslenghi; A Piazza
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

Review 6.  Signaling by the angiotensin-converting enzyme.

Authors:  Ingrid Fleming
Journal:  Circ Res       Date:  2006-04-14       Impact factor: 17.367

7.  Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery.

Authors:  Alessandro Parolari; Luciana Mussoni; Marta Frigerio; Moreno Naliato; Francesco Alamanni; Andrea Galanti; Giuseppe Fiore; Fabrizio Veglia; Elena Tremoli; Paolo Biglioli; Marina Camera
Journal:  J Thorac Cardiovasc Surg       Date:  2005-08       Impact factor: 5.209

8.  Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface.

Authors:  R Shreeniwas; S Koga; M Karakurum; D Pinsky; E Kaiser; J Brett; B A Wolitzky; C Norton; J Plocinski; W Benjamin
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

9.  Tetranectin: a novel secretory protein from human monocytes.

Authors:  H Nielsen; I Clemmensen; A Kharazmi
Journal:  Scand J Immunol       Date:  1993-01       Impact factor: 3.487

10.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

Authors:  J H Jansson; T K Nilsson; O Johnson
Journal:  Br Heart J       Date:  1991-11
View more
  6 in total

1.  Endothelial-Dependent Vasomotor Dysfunction in Infants After Cardiopulmonary Bypass.

Authors:  Luke T Krispinsky; Ryan J Stark; David A Parra; Liming Luan; David P Bichell; John B Pietsch; Fred S Lamb
Journal:  Pediatr Crit Care Med       Date:  2020-01       Impact factor: 3.624

2.  Advanced glycation end-products and insulin signaling in granulosa cells.

Authors:  Evanthia Diamanti-Kandarakis; Antonios Chatzigeorgiou; Efstathia Papageorgiou; Dimitrios Koundouras; Michael Koutsilieris
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-07

3.  Raised plasma Robo4 and cardiac surgery-associated acute kidney injury.

Authors:  Anne Burke-Gaffney; Tatiana Svermova; Sharon Mumby; Simon J Finney; Timothy W Evans
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 4.  Potential biomarkers for predicting outcomes in CABG cardiothoracic surgeries.

Authors:  Isabel Preeshagul; Rajendra Gharbaran; Kyung Hwa Jeong; Ahmed Abdel-Razek; Leonard Y Lee; Elie Elman; K Stephen Suh
Journal:  J Cardiothorac Surg       Date:  2013-07-18       Impact factor: 1.637

Review 5.  Angiotensin II: a new therapeutic option for vasodilatory shock.

Authors:  Rachel L Bussard; Laurence W Busse
Journal:  Ther Clin Risk Manag       Date:  2018-07-26       Impact factor: 2.423

6.  Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis.

Authors:  Kenneth McDonald; Nadezhda Glezeva; John Baugh; Chris J Watson; Patrick Collier; James O'Reilly; Eoin O'Connell; Isaac Tea; Adam Russell-Hallinan; Claire Tonry; Steve Pennington; Joe Gallagher; Mark Ledwidge
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.